References
- Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001;135:41-50.
- Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103-20. 10.1093/cid/ciq257
- Naber KG, Funfstuck R, Wagenlehner FME. Aktuelle Empfehlungen zur Antibiotikatherapie von Harnwegsinfektionen. Urologie Scan. 2015;2:57-78. doi 10.1055/s-0034-1391490.
- Jovanović A, Stevanović R, Pristaš I, Stanić A, Petrovčić M, Benković V, et al. Učestalost, dijagnostika i liječenje infekcija mokraćnog sustava u ordinacijama obiteljske medicine. Medicus. 2006;15:339-44.
- Croatian Institute for Public Health. Croatian Health Statistics Yearbook 2014. Accessed April 15th, 2017 at: http://www.hzjz.hr/wp-content/uploads/2015/05/ljetopis_2014.pdf
- Škerk V, Tambić Andrašević A, Andrašević S, Sušić E, Mlinarić Džepina A, Mađarić V, et al. Smjernice antimikrobnog liječenja i profilakse infekcija mokraćnog sustava. Accessed April 15th, 2017 at: http://iskra.bfm.hr/hrv/guidlinesarticle.aspx?id=62
- Škerk V, Tambić Andrašević A, Sušić E. Dopune i promjene ISKRA hrvatskih nacionalnih smjernica za liječenje i profilaksu infekcija mokraćnog sustava u odraslih. Infektol Glasnik. 2014;34:177-81.
- Croatian Institute for Health Insurance. Osnovna lista lijekova HZZO – u primjeni od 18.02.2016. Accessed March 10th, 2017 at: http://www.hzzo.hr/zdravstveni-sustav-rh/trazilica-za-lijekove-s-vazecih-lista/
- Desgrandchamps D. Increasing rate of in vitro resistance to ciprofloxacin and norfloxacin in isolates from urine specimens. Antimicrob Agents Chemother. 1989;33:595-96.
- Kresken M, Wiedemann B. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother. 1988;32:1285-88.
- European Antimicrobial Resistance Surveillance Network (EARS-Net). Accessed March 15th, 2017 at: http://ecdc.europa.eu/en/activities/diseaseprogrammes/ARHAI/Pages/surveillance_networks.aspx#sthash.P8Th57h6.dpuf
- Tambić Andrašević A, Tambić T, Katalinić Janković V, Payerl Pal M, Bukovski S, Butić I, et al. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2014. godini. Zagreb: Akademija medicinskih znanosti Hrvatske, 2015. Accessed April 22nd, 2017 at: http://www.iskra.bfm.hr/hrv/Resistance.aspx?id=66
- Tambić Andrašević A, Tambić T, Katalinić Janković V, Payerl Pal M, Bukovski S, Butić I, et al. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2013. godini. Zagreb: Akademija medicinskih znanosti Hrvatske, 2014. Accessed April 22nd, 2017 at: http://www.iskra.bfm.hr/hrv/Resistance.aspx?id=66
- Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). J Antimicrob Chemother. 2011;66(Suppl 6):vi3-12. 10.1093/jac/dkr453
- Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87. 10.1016/S0140-6736(05)17907-0
- Aarason VA, Kristinsson KG, Sigurdsson JA, Stefansdottir G, Molstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. Brit Med J. 1996;313:387.
- European antimicrobial consumption surveillance. Accessed March 31th, 2017 at: https://ecdc.europa.eu/en/antimicrobial-consumption/surveillance-and-disease-data/report-protocol
- Naber KG. Neue Aspekte zur Diagnose und Therapie der unkomplizierten Zystitis. Urologe. 2014;53:1489-94.
- Wagenlehner FME, Schmiemann G, Hoyme U et al. Epidemiologie, Diagnostik, Therapie und Management unkomplizierter bakterieller ambulanterworbener Harnwegsinfektionen bei erwachsenen Patienten (Langfassung). S-3 Leitlinie AWMF-Register-Nr. 043/044 Harnwegsinfektionen, 2010. Accessed April 8th, 2017 at: http://www.awmf.org
- Croatian agency for medicines (HALMED). Izviješće o potrošnji lijekova u Republici Hrvatskoj u 2014. godini. Accessed April 8th, 2017 at: http://www.halmed.hr/Novosti-i-edukacije/Publikacije-i-izvjesca/Izvjesca-o-potrosnji-lijekova/Izvjesce-o-prometu-lijekova-u-Republici-Hrvatskoj-u-2014/#Tablica_1
- Tabibian JH, Gornbein J, Heidari A, Dien SL, Lau VH, Chahal P, et al. Uropathogens and host characteristics. J Clin Microbiol. 2008;46:3980-6.
- Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E, et al. The global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens. 2016;5:10.
- McQuiston Haslund J, Rosborg Dinesen M, Sternhagen Nielsen AB, Llor C, Bjerrum L. Different recommendations for empiric first-choice antibiotic treatment of uncomplicated urinary tract infections in Europe. Scand J Prim Health Care. 2013;31:235-40. 10.3109/02813432.2013.844410
- Grabe M, Bjerklund-Johansen TE, Bartoletti R, Tai C, Cek M, Koves B, et al. Guidelines on urological infections. Arnhem: European Association of Urology, 2014: Part 19:1-107. Accessed February 25th, 2017 at: http://www.uroweb.org/gls/pdf/19%20Urological%20infections_LR.pdf
- Cunha BA. New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited. Med Clin N Am. 2006;90: 1089-107. 10.1016/j.mcna.2006.07.006
- Cunha BA. Empiric therapy of genitourinary tract infections. In: Antibiotic essentials. Burlington: Jones and Bartlett Learning, 2012:103.
- Guay DR. An update on the role of nitrofurans in the management of urinary tract infections. Drugs. 2001;61:353-64.
- McOsker CC, Fitzpatrick PM. Nitrofurantoin: preferred empiric therapy for community-acquired lower urinary tract infections. J Antimicrob Chemother. 1994;33:23-30.
- Vlahović Palčevski V, Abram M (editors). Smjernice za propisivanje antimikrobnih lijekova u primarnoj zdravstvenoj zaštiti 2014./2015. 2nd ed. Rijeka: Medicinski fakultet, 2015:38-40.
- ESAC-Net. Distribution of antimicrobial consumption by antimicrobial group. Accessed March 3rd, 2018 at: https://ecdc.europa.eu/en/antimicrobial-consumption/database/distribution-by-antimicrobial-group
- WHO Collaborating Centre for Drug Statistics Methodology. Antiinfectives for systemic use. Accessed March 2nd, 2018 at: https://www.whocc.no/atc_ddd_index/?code=J01&showdescription=no
- Norfloxacin. Martindale. The complete drug reference (Sweetman SC ed.), Pharmaceutical Press. 36th ed. 2009:309.
- Metz-Gercek S, Maieron A, Strauß R, Wieninger P, ApfalterP, Mittermayer H. Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria. BMC Infect Dis. 2009;9:61 10.1186/1471-2334-9-61
- Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, et al. A cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis. 2014;14:381-7. 10.1016/S1473-3099(14)70071-4
- Glinz D, Leon Reyes S, Saccilotto R, Widmer AF, Zeller A, Bucher HC, et al. Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide survey. J Antimicrob Chemother. 2017;72: 3205-12. 10.1093/jac/dkx278
- Titelman E, Iversen A, Kahlmeter G, Giske CG. Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae. APMIS. 2011;119:853-63.
- Dalhoff A. Resistance surveillance studies: a multifaceted problem - the fluoroquinolone example. Infection. 2012;40:239-62. 10.1007/s15010-012-0257-2
- Mahesh E, Medha Y, Indumathi VA, Kumar PS, Khan MW, Punith K. Community-acquired urinary tract infection in the elderly. Br J Med Pract. 2011;4:a406.
- Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, et al. Epidemiology and clinical features of infections caused by extended spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004;42:1089-94.
- Davis A, Obi B, Ingram M. Investigating urinary tract infections in children. BMJ. 2013;346:e8654. 10.1136/bmj.e8654
- Urifos (fosfomicin): summary of product characteristics. HALMED, 2016. Accessed Marh 3rd, 2018 at: http://www.halmed.hr/Lijekovi/Baza-lijekova/Urifos-2-g-granule-za-oralnu-otopinu/12619/
- Milošević D, Batinić D, Trkulja V, Tambić Andrašević A, Filipović Grčić B, Vrljičak K, et al. Rational therapy of urinary tract infections in children in Croatia. Acta Clin Croat. 2016;55:428-39. 10.20471/acc.2016.55.03.12
- Scottish Intercollegiate Guidelines Network. Management of suspected bacterial urinary tract infections in adults: a national clinical guideline. SIGN July 2012. Accessed February 2nd, 2017 at: http://www.sign.ac.uk/guidelines/fulltext/88/
- Baerheim A. Empyrical treatment uncomplicated cystitis: keep it simple. BMJ. 2001;323:1197-8.